Your browser doesn't support javascript.
loading
Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis - An animal experimental prospective cohort study.
Mirus, M; Tokalov, S V; Wolf, G; Heinold, J; Prochnow, V; Abolmaali, N.
Afiliação
  • Mirus M; Biological and Molecular Imaging, OncoRay - National Center for Radiation Research in Oncology, Dresden, Germany.
  • Tokalov SV; Department of Anaesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, University of Technology, Dresden, Germany.
  • Wolf G; Biological and Molecular Imaging, OncoRay - National Center for Radiation Research in Oncology, Dresden, Germany.
  • Heinold J; 3Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Prochnow V; Biological and Molecular Imaging, OncoRay - National Center for Radiation Research in Oncology, Dresden, Germany.
  • Abolmaali N; 4Institute of Clinical Chemistry and Laboratory Medicine, Carl Gustav Carus Medical Faculty, University of Technology, Dresden, Germany.
Eur Radiol Exp ; 1(1): 15, 2017.
Article em En | MEDLINE | ID: mdl-29708186
ABSTRACT

BACKGROUND:

To investigate vascular-related pathophysiological characteristics of two human lung cancers with modifiable vascularisation using MRI and CT.

METHODS:

Tumour xenografts with modifiable vascularisation were established in 71 rats (approval by the Animal Care Committee was obtained) by subcutaneous transplantation of two human non-small-cell lung cancer (NSCLC) cells (A549, H1299) either alone or co-transplanted with vascular growth promoters. The vascularity of the tumours was assessed noninvasively by MRI diffusion-weighted-imaging (DWI), T2-weighted, and time-of-flight (TOF) sequences) as well as contrast-enhanced CT (CE-CT), using clinical scanners. As a reference standard, histological examinations (CD-31, fluorescent beads) were done after explantation.

RESULTS:

Microvessel density (MVD) was higher in co-transplanted tumours (171 ± 19 number/mm2) than in non-co-transplanted tumours (111 ± 11 number/mm2; p = 0.002). Co-transplanted tumours showed higher growth rates and larger tumour vessels at TOF-MRI as well as larger necrotic areas at CE-CT. In co-transplanted tumours, DWI revealed higher cellularity (lower minimal ADCdiff 166 ± 15 versus 346 ± 27 mm2/s × 10-6; p < 0.001), highly necrotic areas (higher maximal ADCdiff 1695 ± 65 versus 1320 ± 59 mm2/s × 10-6; p < 0.001), and better-perfused tumour stroma (higher ADCperf 723 ± 36 versus 636 ± 51 mm2/s × 10-6; p = 0.005). Significant correlations were found using qualitative and quantitative parameters maximal ADCperf and MVD (r = 0.326); maximal ADCdiff and relative necrotic volume on CE-CT (r = 0.551); minimal ADCdiff and MVD (r = -0.395).

CONCLUSIONS:

Pathophysiological differences related to vascular supply in two human lung cancer cell lines with modifiable vascularity are quantifiable with clinical imaging techniques. Imaging parameters of vascularisation correlated with the results of histology. DWI was able to characterise both the extent of necrosis and the level of perfusion.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research Idioma: En Revista: Eur Radiol Exp Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research Idioma: En Revista: Eur Radiol Exp Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha